Citadel Advisors
PLSE icon

Citadel Advisors’s Pulse Biosciences PLSE Stock Holding History

Citadel Advisors’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.07M Buy
142,150
+100,620
+242% +$1.86M ﹤0.01% 5219
2025
Q4 		$570K Buy
41,530
+4,412
+12% +$68.8K ﹤0.01% 8711
2025
Q3 		$657K Buy
37,118
+23,685
+176% +$375K ﹤0.01% 8480
2025
Q2 		$203K Sell
13,433
-12,254
-48% -$203K ﹤0.01% 10654
2025
Q1 		$413K Buy
+25,687
New +$479K ﹤0.01% 8902
2024
Q4 		– Sell
-354
Closed -$6.24K – 15171
2024
Q3 		$6.21K Buy
+354
New +$6.04K ﹤0.01% 13433
2024
Q2 		– Sell
-54,082
Closed -$509K – 15117
2024
Q1 		$471K Buy
54,082
+50,382
+1,362% +$463K ﹤0.01% 8533
2023
Q4 		$45.3K Buy
3,700
+3,269
+758% +$22.6K ﹤0.01% 11884
2023
Q3 		$1.74K Buy
+431
New +$2.68K ﹤0.01% 13815
2023
Q2 		– Sell
-13
Closed -$44 – 15030
2023
Q1 		$44 Sell
13
-24,552
-100% -$74K ﹤0.01% 14611
2022
Q4 		$68K Buy
+24,565
New +$55.2K ﹤0.01% 11742
2022
Q3 		– Sell
-63,401
Closed -$103K – 13359
2022
Q2 		$97K Buy
+63,401
New +$159K ﹤0.01% 11439
2020
Q2 		– Sell
-12,555
Closed -$90K – 10336
2020
Q1 		$90K Buy
+12,555
New +$130K ﹤0.01% 8700
2018
Q2 		– Sell
-31,819
Closed -$431K – 9170
2018
Q1 		$431K Sell
31,819
-306,087
-91% -$5.81M ﹤0.01% 6156
2017
Q4 		$7.97M Buy
+337,906
New +$7.97M ﹤0.01% 1956

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Citadel Advisors's PLSE Position: Q1 2026 in Review

Citadel Advisors increased its Pulse Biosciences (PLSE) stake by 242% in Q1 2026, buying an estimated $1.86M and bringing the position to 142,150 shares worth $3.07M. The position accounts for ﹤0.01% of the portfolio, ranked #5219.

Citadel Advisors first reported a position in PLSE in Q4 2017 and has held it in 15 quarters since. The position peaked at $7.97M in Q4 2017. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • Citadel Advisors held 142,150 shares of Pulse Biosciences worth $3.07M as of Q1 2026.
  • Citadel Advisors bought 100,620 Pulse Biosciences shares in Q1 2026, an estimated $1.86M.
  • Pulse Biosciences made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5219 holding.
  • Citadel Advisors first reported a position in Pulse Biosciences in Q4 2017 and has held it in 15 quarters since.
  • Citadel Advisors's Pulse Biosciences position peaked at $7.97M in Q4 2017.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.